Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134121) titled 'A Real-World Retrospective Multi-Omics Study of Cervical Neuroendocrine Carcinoma' on Oct. 11.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Peking Union Medical College Hospital
Condition:
Neuroendocrine Carcinoma of the Cervix
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-11-01
Target Sample Size: Observation group of cervical neuroendocrine carcinoma:120;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=346623
Disclaimer: Curated by HT Syndication....